You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaccines, Synthetic

Showing 1 - 25 of 3,443
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

Enrolling by invitation
  • Cancer
  • Solid Tumor
  • Personalized Synthetic Long Peptide Vaccine
  • San Francisco, California
    Quest Clinical Research
Feb 20, 2023

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Optimized neoantigen synthetic long peptide

Recruiting
  • Pancreas Cancer
  • +2 more
  • Optimized neoantigen synthetic long peptide vaccine
  • Poly-ICLC
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 23, 2023

COVID-19 Infection, Hematopoietic and Lymphoid System Tumor, Leukemia Trial in Duarte (COVID-19 Vaccine, Diagnostic Laboratory

Recruiting
  • COVID-19 Infection
  • +4 more
  • COVID-19 Vaccine
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 2, 2021

HIV Trial in United States (FP conjugate vaccine (25 mcg), FP conjugate vaccine (200 mcg), Trimer 6931 (100 mcg))

Not yet recruiting
  • HIV
  • FP conjugate vaccine (25 mcg)
  • +5 more
  • Los Angeles, California
  • +6 more
Jul 19, 2022

HIV Trial in Pittsburgh (rgp120/HIV-1 SF-2, Env 2-3, HIVAC-1e)

Completed
  • HIV Infections
  • rgp120/HIV-1 SF-2
  • +3 more
  • Pittsburgh, Pennsylvania
    JHU AVEG
Oct 27, 2021

HIV Trial in United States (Aluminum hydroxide, MF59, rgp120/HIV-1IIIB)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +5 more
  • Los Angeles, California
  • +9 more
Oct 27, 2021

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), gp160 MN/LAI-2, ALVAC(1)120(B,MN)GNP (vCP1433))

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • +4 more
  • Birmingham, Alabama
  • +5 more
Oct 27, 2021

HIV Trial in Nashville, Seattle (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • HIVAC-1e
  • gp160 Vaccine (MicroGeneSys)
  • Nashville, Tennessee
  • +1 more
Oct 26, 2021

HIV Trial in Rochester, Seattle (gp160 Vaccine (Immuno-AG), rgp120/HIV-1IIIB, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • +4 more
  • Rochester, New York
  • +1 more
Oct 28, 2021

HIV Trial in Saint Louis, Rochester, Nashville (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +2 more
Oct 28, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Orange, California
  • +15 more
Aug 23, 2022

HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (MTP-PE/MF59, Env 2-3)

Completed
  • HIV Infections
  • HIV Seronegativity
  • MTP-PE/MF59
  • Env 2-3
  • Rochester, New York
  • +2 more
Oct 28, 2021

HIV Trial in Saint Louis, Pittsburgh, Nashville (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +2 more
Oct 27, 2021

HIV Trial in Pittsburgh, Nashville (Hepatitis B Vaccine (Recombinant), gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • Hepatitis B Vaccine (Recombinant)
  • gp160 Vaccine (MicroGeneSys)
  • Pittsburgh, Pennsylvania
  • +1 more
Oct 27, 2021

Safety, Vaccine Reaction, Vaccine Adverse Reaction Trial (S.opt.FL COVID-19 pDNA vaccine)

Not yet recruiting
  • Safety
  • +3 more
  • S.opt.FL COVID-19 pDNA vaccine
  • (no location specified)
Dec 22, 2021

HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)

Completed
  • HIV Infections
  • HIV Seronegativity
  • Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
  • +3 more
  • Baltimore, Maryland
    JHU AVEG
Oct 27, 2021

Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)

Recruiting
  • Shigella
  • SF2a-TT15 Shigella Vaccine
  • +2 more
  • Baltimore, Maryland
    University of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022

Virus Diseases Trial in London (ConM SOSIP 50 ug and ConS UFO 50 ug, Mos3.1 100 ug, Mos3.2 100 ug)

Active, not recruiting
  • Virus Diseases
  • ConM SOSIP 50 ug and ConS UFO 50 ug
  • +4 more
  • London, Please Select..., United Kingdom
    NIHR Imperial Clinical Research Facility
Jul 25, 2022

Non Small Cell Lung Cancer Trial in Leiden, Rotterdam (TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51))

Recruiting
  • Non Small Cell Lung Cancer
  • TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)
  • Leiden, Zuid-Holland, Netherlands
  • +1 more
Jun 1, 2023

HIV Trial in Saint Louis (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
    St. Louis Univ. School of Medicine AVEG
Oct 28, 2021

HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +2 more
  • Saint Louis, Missouri
  • +3 more
Oct 28, 2021

HIV Trial in United States (TBC-3B Vaccine, Smallpox Vaccine)

Completed
  • HIV Infections
  • TBC-3B Vaccine
  • Smallpox Vaccine
  • Saint Louis, Missouri
  • +4 more
Oct 27, 2021

HIV Trial in Seattle (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • HIVAC-1e
  • gp160 Vaccine (MicroGeneSys)
  • Seattle, Washington
    Children's Hospital & Medical Center / Seattle ACTU
Oct 26, 2021

HIV Trial in United States (rgp120/HIV-1MN, rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • rgp120/HIV-1MN
  • rgp120/HIV-1 SF-2
  • Birmingham, Alabama
  • +6 more
Oct 28, 2021

HIV Trial in Baltimore (ALVAC-HIV gp160MN (vCP125), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV gp160MN (vCP125)
  • +2 more
  • Baltimore, Maryland
    JHU AVEG
Oct 27, 2021